*ST生物：11月14日召开董事会会议

Group 1 - The core point of the article is that *ST Bio announced a board meeting to discuss a proposal regarding debt transfer and related transactions [1] - For the first half of 2025, *ST Bio's revenue composition is as follows: stem cell industry accounts for 83.88%, energy-saving technology services account for 15.87%, and other businesses account for 0.25% [1] - As of the report date, *ST Bio has a market capitalization of 3.4 billion yuan [1]